Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A flavivirus protein M-derived peptide directly permeabilizes mitochondrial membranes, triggers cell death and reduces human tumor growth in nude mice.
Brabant M, Baux L, Casimir R, Briand JP, Chaloin O, Porceddu M, Buron N, Chauvier D, Lassalle M, Lecoeur H, Langonné A, Dupont S, Déas O, Brenner C, Rebouillat D, Muller S, Borgne-Sanchez A, Jacotot E. Brabant M, et al. Among authors: lassalle m. Apoptosis. 2009 Oct;14(10):1190-203. doi: 10.1007/s10495-009-0394-y. Apoptosis. 2009. PMID: 19693674
Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells.
Borgne-Sanchez A, Dupont S, Langonné A, Baux L, Lecoeur H, Chauvier D, Lassalle M, Déas O, Brière JJ, Brabant M, Roux P, Péchoux C, Briand JP, Hoebeke J, Deniaud A, Brenner C, Rustin P, Edelman L, Rebouillat D, Jacotot E. Borgne-Sanchez A, et al. Among authors: lassalle m. Cell Death Differ. 2007 Mar;14(3):422-35. doi: 10.1038/sj.cdd.4402018. Epub 2006 Aug 4. Cell Death Differ. 2007. PMID: 16888644
Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer.
Legrier ME, Bièche I, Gaston J, Beurdeley A, Yvonnet V, Déas O, Thuleau A, Château-Joubert S, Servely JL, Vacher S, Lassalle M, Depil S, Tucker GC, Fontaine JJ, Poupon MF, Roman-Roman S, Judde JG, Decaudin D, Cairo S, Marangoni E. Legrier ME, et al. Among authors: lassalle m. Br J Cancer. 2016 Jan 19;114(2):177-87. doi: 10.1038/bjc.2015.398. Epub 2015 Dec 22. Br J Cancer. 2016. PMID: 26695443 Free PMC article.
Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies.
Lang H, Béraud C, Cabel L, Fontugne J, Lassalle M, Krucker C, Dufour F, Groeneveld CS, Dixon V, Meng X, Kamoun A, Chapeaublanc E, De Reynies A, Gamé X, Rischmann P, Bieche I, Masliah-Planchon J, Beaurepere R, Allory Y, Lindner V, Misseri Y, Radvanyi F, Lluel P, Bernard-Pierrot I, Massfelder T. Lang H, et al. Among authors: lassalle m. Front Oncol. 2022 Aug 11;12:930731. doi: 10.3389/fonc.2022.930731. eCollection 2022. Front Oncol. 2022. PMID: 36033544 Free PMC article.
Correction: ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target.
Bikeye SN, Colin C, Marie Y, Vampouille R, Ravassard P, Rousseau A, Boisselier B, Idbaih A, Calvo CF, Leuraud P, Lassalle M, El Hallani S, Delattre JY, Sanson M. Bikeye SN, et al. Among authors: lassalle m. Cancer Cell Int. 2011 Apr 15;11:10. doi: 10.1186/1475-2867-11-10. Cancer Cell Int. 2011. PMID: 21496261 Free PMC article. No abstract available.
ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target.
Bikeye SN, Colin C, Marie Y, Vampouille R, Ravassard P, Rousseau A, Boisselier B, Idbaih A, Calvo CF, Leuraud P, Lassalle M, El Hallani S, Delattre JY, Sanson M. Bikeye SN, et al. Among authors: lassalle m. Cancer Cell Int. 2010 Jan 11;10:1. doi: 10.1186/1475-2867-10-1. Cancer Cell Int. 2010. PMID: 20142996 Free PMC article.
Number of passes and outcome of endovascular treatment of anterior circulation large core ischemic stroke: insights from the Endovascular Treatment in Ischemic Stroke (ETIS) registry.
Lambrou V, Gory B, Lapergue B, Marnat G, Pop R, Calviere L, Anadani M, Blanc R, Finitsis SN; ETIS Study Group. Lambrou V, et al. J Neurointerv Surg. 2024 May 30:jnis-2024-021857. doi: 10.1136/jnis-2024-021857. Online ahead of print. J Neurointerv Surg. 2024. PMID: 38816202
Prevalence of chronic kidney disease in France: methodological considerations and pitfalls with the use of Health claims databases.
Couchoud C, Raffray M, Lassalle M, Duisenbekov Z, Moranne O, Erbault M, Lazareth H, Parmentier C, Guebre-Egziabher F, Hamroun A, Metzger M, Mansouri I, Goldberg M, Zins M, Bayat-Makoei S, Kab S. Couchoud C, et al. Among authors: lassalle m. Clin Kidney J. 2024 Apr 23;17(5):sfae117. doi: 10.1093/ckj/sfae117. eCollection 2024 May. Clin Kidney J. 2024. PMID: 38774439 Free PMC article.
105 results